Top Markets
Coin of the day
Grace Therapeutics, Inc. Grace Therapeutics, Inc.

Grace Therapeutics, Inc.

GRCE
Peringkat dalam Saham #27034
Grace Therapeutics, Inc. specializes in the creation and commercialization of... Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. Established in 2002, the enterprise previously operated under the name Acasti Pharma Inc., before officially adopting Grace Therapeutics, Inc. in October 2024. The company's main offices are located in Princeton, New Jersey.
Harga Saham
$2.18
Terakhir disinkronkan: 2026-08-19
Kapitalisasi Pasar
$35.55M
Perubahan (1 hari)
2.57%
Perubahan (1 tahun)
-33.19%
Negara
US
Perdagangan Grace Therapeutics, Inc. (GRCE)

Kategori

Riwayat pemecahan saham untuk Grace Therapeutics, Inc. (GRCE)
Saham Grace Therapeutics, Inc. (simbol: GRCE) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 20, 2026.
Satu lembar saham GRCE yang dibeli sebelum Aug 20, 2026 sekarang setara dengan 0 lembar saham GRCE.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH